Cargando…
Structure–Affinity Relationships and Structure–Kinetics Relationships of Pyrido[2,1-f]purine-2,4-dione Derivatives as Human Adenosine A(3) Receptor Antagonists
[Image: see text] We expanded on a series of pyrido[2,1-f]purine-2,4-dione derivatives as human adenosine A(3) receptor (hA(3)R) antagonists to determine their kinetic profiles and affinities. Many compounds showed high affinities and a diverse range of kinetic profiles. We found hA(3)R antagonists...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2017
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601358/ https://www.ncbi.nlm.nih.gov/pubmed/28806076 http://dx.doi.org/10.1021/acs.jmedchem.7b00950 |
_version_ | 1783264375114563584 |
---|---|
author | Xia, Lizi Burger, Wessel A. C. van Veldhoven, Jacobus P. D. Kuiper, Boaz J. van Duijl, Tirsa T. Lenselink, Eelke B. Paasman, Ellen Heitman, Laura H. IJzerman, Adriaan P. |
author_facet | Xia, Lizi Burger, Wessel A. C. van Veldhoven, Jacobus P. D. Kuiper, Boaz J. van Duijl, Tirsa T. Lenselink, Eelke B. Paasman, Ellen Heitman, Laura H. IJzerman, Adriaan P. |
author_sort | Xia, Lizi |
collection | PubMed |
description | [Image: see text] We expanded on a series of pyrido[2,1-f]purine-2,4-dione derivatives as human adenosine A(3) receptor (hA(3)R) antagonists to determine their kinetic profiles and affinities. Many compounds showed high affinities and a diverse range of kinetic profiles. We found hA(3)R antagonists with very short residence time (RT) at the receptor (2.2 min for 5) and much longer RTs (e.g., 376 min for 27 or 391 min for 31). Two representative antagonists (5 and 27) were tested in [(35)S]GTPγS binding assays, and their RTs appeared correlated to their (in)surmountable antagonism. From a k(on)–k(off)–K(D) kinetic map, we divided the antagonists into three subgroups, providing a possible direction for the further development of hA(3)R antagonists. Additionally, we performed a computational modeling study that sheds light on the crucial receptor interactions, dictating the compounds’ binding kinetics. Knowledge of target binding kinetics appears useful for developing and triaging new hA(3)R antagonists in the early phase of drug discovery. |
format | Online Article Text |
id | pubmed-5601358 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | American Chemical
Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-56013582017-09-19 Structure–Affinity Relationships and Structure–Kinetics Relationships of Pyrido[2,1-f]purine-2,4-dione Derivatives as Human Adenosine A(3) Receptor Antagonists Xia, Lizi Burger, Wessel A. C. van Veldhoven, Jacobus P. D. Kuiper, Boaz J. van Duijl, Tirsa T. Lenselink, Eelke B. Paasman, Ellen Heitman, Laura H. IJzerman, Adriaan P. J Med Chem [Image: see text] We expanded on a series of pyrido[2,1-f]purine-2,4-dione derivatives as human adenosine A(3) receptor (hA(3)R) antagonists to determine their kinetic profiles and affinities. Many compounds showed high affinities and a diverse range of kinetic profiles. We found hA(3)R antagonists with very short residence time (RT) at the receptor (2.2 min for 5) and much longer RTs (e.g., 376 min for 27 or 391 min for 31). Two representative antagonists (5 and 27) were tested in [(35)S]GTPγS binding assays, and their RTs appeared correlated to their (in)surmountable antagonism. From a k(on)–k(off)–K(D) kinetic map, we divided the antagonists into three subgroups, providing a possible direction for the further development of hA(3)R antagonists. Additionally, we performed a computational modeling study that sheds light on the crucial receptor interactions, dictating the compounds’ binding kinetics. Knowledge of target binding kinetics appears useful for developing and triaging new hA(3)R antagonists in the early phase of drug discovery. American Chemical Society 2017-08-14 2017-09-14 /pmc/articles/PMC5601358/ /pubmed/28806076 http://dx.doi.org/10.1021/acs.jmedchem.7b00950 Text en Copyright © 2017 American Chemical Society This is an open access article published under a Creative Commons Non-Commercial No Derivative Works (CC-BY-NC-ND) Attribution License (http://pubs.acs.org/page/policy/authorchoice_ccbyncnd_termsofuse.html) , which permits copying and redistribution of the article, and creation of adaptations, all for non-commercial purposes. |
spellingShingle | Xia, Lizi Burger, Wessel A. C. van Veldhoven, Jacobus P. D. Kuiper, Boaz J. van Duijl, Tirsa T. Lenselink, Eelke B. Paasman, Ellen Heitman, Laura H. IJzerman, Adriaan P. Structure–Affinity Relationships and Structure–Kinetics Relationships of Pyrido[2,1-f]purine-2,4-dione Derivatives as Human Adenosine A(3) Receptor Antagonists |
title | Structure–Affinity
Relationships and Structure–Kinetics
Relationships of Pyrido[2,1-f]purine-2,4-dione
Derivatives as Human Adenosine A(3) Receptor Antagonists |
title_full | Structure–Affinity
Relationships and Structure–Kinetics
Relationships of Pyrido[2,1-f]purine-2,4-dione
Derivatives as Human Adenosine A(3) Receptor Antagonists |
title_fullStr | Structure–Affinity
Relationships and Structure–Kinetics
Relationships of Pyrido[2,1-f]purine-2,4-dione
Derivatives as Human Adenosine A(3) Receptor Antagonists |
title_full_unstemmed | Structure–Affinity
Relationships and Structure–Kinetics
Relationships of Pyrido[2,1-f]purine-2,4-dione
Derivatives as Human Adenosine A(3) Receptor Antagonists |
title_short | Structure–Affinity
Relationships and Structure–Kinetics
Relationships of Pyrido[2,1-f]purine-2,4-dione
Derivatives as Human Adenosine A(3) Receptor Antagonists |
title_sort | structure–affinity
relationships and structure–kinetics
relationships of pyrido[2,1-f]purine-2,4-dione
derivatives as human adenosine a(3) receptor antagonists |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601358/ https://www.ncbi.nlm.nih.gov/pubmed/28806076 http://dx.doi.org/10.1021/acs.jmedchem.7b00950 |
work_keys_str_mv | AT xializi structureaffinityrelationshipsandstructurekineticsrelationshipsofpyrido21fpurine24dionederivativesashumanadenosinea3receptorantagonists AT burgerwesselac structureaffinityrelationshipsandstructurekineticsrelationshipsofpyrido21fpurine24dionederivativesashumanadenosinea3receptorantagonists AT vanveldhovenjacobuspd structureaffinityrelationshipsandstructurekineticsrelationshipsofpyrido21fpurine24dionederivativesashumanadenosinea3receptorantagonists AT kuiperboazj structureaffinityrelationshipsandstructurekineticsrelationshipsofpyrido21fpurine24dionederivativesashumanadenosinea3receptorantagonists AT vanduijltirsat structureaffinityrelationshipsandstructurekineticsrelationshipsofpyrido21fpurine24dionederivativesashumanadenosinea3receptorantagonists AT lenselinkeelkeb structureaffinityrelationshipsandstructurekineticsrelationshipsofpyrido21fpurine24dionederivativesashumanadenosinea3receptorantagonists AT paasmanellen structureaffinityrelationshipsandstructurekineticsrelationshipsofpyrido21fpurine24dionederivativesashumanadenosinea3receptorantagonists AT heitmanlaurah structureaffinityrelationshipsandstructurekineticsrelationshipsofpyrido21fpurine24dionederivativesashumanadenosinea3receptorantagonists AT ijzermanadriaanp structureaffinityrelationshipsandstructurekineticsrelationshipsofpyrido21fpurine24dionederivativesashumanadenosinea3receptorantagonists |